Microbial Omega-3 DHA

About Neuron Biopharma

Neuron Biopharma operates a dual business model spanning diagnostics and industrial biotechnology. Its pharmaceutical division, Neuron Biolabs, focuses on diagnostic tools like AlzTEST® for Alzheimer's, while its industrial biotech arm, Neol Bio, develops microbial fermentation processes for products such as Omega-3 DHA. The company is publicly traded but has faced significant financial challenges, including a creditor bankruptcy proceeding initiated in 2017. Its strategy leverages biotech platforms to address needs in both healthcare and sustainable industrial production.

Therapeutic Areas